What We’ve Learned

ImagingNMD is closely working with pharmaceutical companies to facilitate clinical trials of new drugs for various muscular dystrophies.

Recent Articles

Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS
This study demonstrates the sensitivity of MRI and magnetic resonance spectroscopy (MRS) as a biomarker to detect the effects of corticosteroids on leg muscles. This underlines the potential of MRI/MRS as a biomarker in clinical trials assessing therapeutic interventions for Duchenne muscular dystrophy.
MR biomarkers predict clinical function in Duchenne muscular dystrophy
This study demonstrates a strong relationship between lower extremity MRI and functional measures over a period of 48 months. In addition, MR biomarkers of proximal muscles predicted future ambulatory and clinical milestone status
Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic. Phys Ther.
This article describes how MRI has impacted our understanding of Duchenne muscular dystrophy and discusses implications for physical therapy care for individuals with this rare disease.

Videos & Webinars

Development of Imaging Biomarkers for Becker Muscular Dystrophy

Play Video

Pat Chat with Krista Vandenborne

Play Video

Additional Resources

provides a registry for DMD and BMD, funds research, provides support from a network of experts, educational programing, helps ensure excellence in care in centers around the country and more.

Decode Duchenne Program– free genetictesting and counseling

  • Diagnostic testing
  • Carrier testing

“Advancing diagnosis, care and treatment for those living with neuromuscular diseases”

Provides resources for patients, clinicians, and industry.

“National task force for early identification of childhood neuromuscular disorders.”


  1. Rare disease database
  2. Patient caregiver & resource center
  3. Patient assistance programs

Advances in skeletal muscle biology in health and disease.
Interdisciplinary researchers, industry, and other institutions work together in collaborative ways to enhance the understanding and treatment of neuromuscular diseases.

The center partners with MDA and coordinates care from a collaborative team of specialists available to the patient.

3 articles published in 2018 outline the overall health care for an individual with DMD including early diagnosis, systems review, primary care, emergency management, psychosocial care and transitions of care across the life span. Click here to download the PDF.